Group structure
6 companies in 3 countries
Malaysia1
United States1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading…
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DOLUTEGRAVIR10mg | 5mg · Film | Dolutegravir | United States | Marketed | 2023 |
| EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE200mg; 25mg base; 300mg · Tablet | Emtricitabine, Rilpivirine, Tenofovir disoproxil | United States | Marketed | 2025 |
| HYDROXYCHLOROQUINE SULFATE100mg | 200mg | 300mg | 400mg · Tablet | Hydroxychloroquine | United States | Marketed | 1994 |
| ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE30mg | 5mg | 600mg; 50mg; 300mg | 60mg | 60mg; 5mg; 30mg · Tablet | Abacavir, Dolutegravir, Lamivudine | United States | tentative | 2022 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE50mg; 300mg; 300mg | 50mg/300mg/300mg · Tablet | Dolutegravir, Lamivudine, Tenofovir disoproxil | United States | tentative | 2019 |
| SITAGLIPTIN100mg | 25mg | 50mg · Tablet | Sitagliptin | United States | tentative | 2025 |
| TENOFOVIR ALAFENAMIDE FUMARATE25mg base · Tablet | Tenofovir alafenamide | United States | tentative | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 7 | 3 | 4 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Report an error or request removalCorrections from the company itself are welcome.
Keep Laurus’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.